This study is testing how well a new treatment, called **cilta-cel**, works with different types of medicine plans for people with a disease called multiple myeloma. Multiple myeloma is a type of cancer that affects white blood cells. The study involves a process called **lymphodepletion**, which reduces the number of certain blood cells and is usually done with chemotherapy.
**Key Points:**
- Participants must have a new diagnosis of multiple myeloma and have received 3 to 5 cycles of induction therapy.
- This study involves taking medicines that may include cyclophosphamide and fludarabine, which are types of chemotherapy drugs.
- Participants should be able to follow specific lifestyle rules during the study and should not have severe ongoing side effects from previous treatments.
If you decide to join, you will be part of a research study to help find better treatments for multiple myeloma. Make sure to discuss with your doctor whether this study is a good fit for you, considering your health condition and treatment history.
How understandable was the trial content above?
Hard to understand
Easy to understand